SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Vow ASA (SSHPF) , forward earnings yield 24.21%. PEG 0.04 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 4.1
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 17/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SSHPF
Valuation Multiples
P/E (TTM)0.0
Forward P/E4.1
PEG Ratio0.04
Forward PEG0.04
P/B Ratio0.00
P/S Ratio0.06
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.96
Forward EPS (Est.)$0.05
Book Value / Share$0.00
Revenue / Share$3.55
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield24.21%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.05 |
$171.7M |
$-4.8M |
-2.8% |
| 2017 |
$0.13 |
$247M |
$12.6M |
5.1% |
| 2018 |
$0.28 |
$329.6M |
$26.3M |
8% |
| 2019 |
$-0.14 |
$380.8M |
$-13.5M |
-3.5% |
| 2020 |
$0.26 |
$459.8M |
$27.9M |
6.1% |
| 2021 |
$2.80 |
$454.1M |
$323.3M |
71.2% |
| 2022 |
$0.12 |
$782.8M |
$14.3M |
1.8% |
| 2023 |
$-1.33 |
$918.5M |
$-155.2M |
-16.9% |
| 2024 |
$-0.79 |
$1.02B |
$-90.2M |
-8.9% |
| 2025 |
$-0.96 |
$1.03B |
$-279.34M |
-27% |
